
Blog
Naloxegol Market Regional Analysis, Demand Analysis, and Competitive Outlook (2025–2032)
Naloxegol is a peripherally acting μ-opioid receptor antagonist (PAMORA) primarily indicated for the treatment of opioid-induced constipation (OIC) in adults suffering from chronic non-cancer pain.